Skip to content
  • Reports
  • Podcast Subscribe
  • Log In

Now covering the global biotech industry!
Read More
Topics
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • Log In
Now covering the global biotech industry!
Read More

Home » What’s new » Heptares Therapeutics

Heptares Therapeutics

ADVERTISEMENT
More News!

British Biotech Spin-Offs Get €40M Funding to Treat Narcolepsy

Orexia and Inexia, two new virtual companies spun out of Sosei Heptares, will develop drugs…

By Clara Rodríguez Fernández
February 6, 2019 - 2 minutes
News and Trends

British Biotech Founder Receives the Nobel Prize in Chemistry 2017

Richard Henderson, awarded the Nobel Prize in Chemistry 2017, founded Heptares Therapeutics to apply his Nobel-winning technology…

By Clara Rodríguez Fernández
October 5, 2017 - 2 minutes
News and Trends

Allergan Takes to the Clinic a New Alzheimer’s Drug from a €3Bn Deal

Allergan's partner Heptares Therapeutics has dosed the first patient with a GPCR drug to treat…

By Clara Rodríguez Fernández
September 1, 2017 - 2 minutes
Interview

Pinning Down Elusive Targets: Interviewing the Co-Founder & CSO of Heptares

Heptares is expanding into a range of indications with its GPCR platform. I caught up…

By Evelyn Warner
July 17, 2017 - 6 minutes
In Depth

A Painful Case: How Biotech is trying to Break Through in Analgesia

Just 2% of experimental pain treatments clear Phase II. Why is this challenge so great,…

By Evelyn Warner
June 6, 2017 - 7 minutes
News and Trends

Heptares receives €4.5M Milestone for New Migraine Drug Candidate

The UK biotech attacking notoriously evasive GPCRs has discovered a small molecule that could be…

By Evelyn Warner
May 18, 2017 - 1 minute
News and Trends

Heptares Finds New GPCR Target to Treat Pain, Cancer and Inflammation

Heptares Therapeutics has published the detailed structure and mechanism of action of a difficult-to-target GPCR…

By Clara Rodríguez Fernández
April 27, 2017 - 2 minutes
News and Trends

Heptares Takes Home €11M for its Next-Generation Checkpoint Inhibitor

Heptares Therapeutics has achieved a new milestone in its immuno-oncology collaboration with AstraZeneca triggering an…

By Melanie De Almeida
April 5, 2017 - 3 minutes
Best in Biotech

What are the Best Countries to Recruit Biotech Talents in 2017?

Before the “who to recruit” phase, an important question is “where?” We ran through the…

By External Contributor
March 15, 2017 - 10 minutes
News and Trends

New British Biotech-Academia Alliance takes on Cardiovascular Disease

Heptares Therapeutics and the University of Cambridge have partnered to investigate a novel target for…

By Clara Rodríguez Fernández
January 31, 2017 - 2 minutes
News and Trends

The Largest Deals, Fundraising and Exits of 2016 in European Biotech

Curious about which technologies have attracted the most cash in biotech finance this year? Here's a…

By Clara Rodríguez Fernández
December 26, 2016 - 5 minutes
News and Trends

Drugging the Undruggable: New Acquisition to Boost GPCR Drugs

Heptares Therapeutics has acquired G7 Therapeutics to take control over its GPCR technology, boost its…

By Clara Rodríguez Fernández
November 30, 2016 - 2 minutes
  • 1
  • 2
  • Next Page »
footer logo

Labiotech.eu is the leading digital media covering the global biotech industry.

Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you’ll enjoy reading our stories!

  • About us
  • Inside Labiotech
  • Join Us
  • Advertise
  • Contact
  • Editorial Calendar
  • Site Map
  • Linkedin
  • Twitter
  • Youtube
  • RSS Feed
Made with in Berlin. Labiotech UG, All Rights Reserved -
  • Imprint
  • Privacy Policy

Browse Topics

Search for a topic, country or company name by using the search box

    Popular topics:


    CRISPR mRNA technology CAR-T HIV Cell therapy Diabetes Microbiome Gene therapy Synthetic biology
    Labiotech.eu
    • Log In

    Topics

    • Gene Therapy
    • CRISPR
    • CAR-T
    • Covid-19
    • Microbiome
    • Diabetes
    • Cancer

    Sections

    • News and Trends
    • In Depth
    • Best in Biotech
    • Opinion
    • Interview
    • Infographics
    Show All Topics

    For Members

    • Expert Advice
    • Reports
    • Startup Scout

    More

    • About us
    • Inside Labiotech
    • Join Us
    • Advertise
    • Contact
    • Podcast
    • Biotech Events
    • Awareness Days